A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D

11th Mar, 2026

Gastroenterology

The New England Journal of Medicine

Tobevibart plus elebsiran and tobevibart alone both lowered HDV RNA and ALT levels. The combination resulted in a high incidence of undetectable HDV RNA and an HBsAg level below 10 IU/ml at week 48.

Published By: The New England Journal of Medicine

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

Common Diseases in Clinical Cohorts — Not Always What They Seem

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

Not Otherwise Specified — Season 3: The Forever Crisis of Primary Care: Misunderstandings — NOS Episode 3.3

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

Noninvasive Assessment of Liver Fibrosis

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

Case 36-2025: A 55-Year-Old Woman with Dyspnea, Fatigue, and Gastrointestinal Bleeding

Gastroenterology

11th Mar, 2026

The New England Journal of Medicine

A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D

Related Articles

Common Diseases in Clinical Cohorts — Not Always What They Seem

Not Otherwise Specified — Season 3: The Forever Crisis of Primary Care: Misunderstandings — NOS Episode 3.3

Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia

Noninvasive Assessment of Liver Fibrosis

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Case 36-2025: A 55-Year-Old Woman with Dyspnea, Fatigue, and Gastrointestinal Bleeding

Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas

A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D

Related Articles

Common Diseases in Clinical Cohorts — Not Always What They Seem

Not Otherwise Specified — Season 3: The Forever Crisis of Primary Care: Misunderstandings — NOS Episode 3.3

Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia

Noninvasive Assessment of Liver Fibrosis

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Case 36-2025: A 55-Year-Old Woman with Dyspnea, Fatigue, and Gastrointestinal Bleeding

Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas